Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 30;48(3):765-773.
doi: 10.1042/BST20190109.

Functional heterogeneity in senescence

Affiliations
Review

Functional heterogeneity in senescence

Kristina Kirschner et al. Biochem Soc Trans. .

Abstract

Senescence is a tumour suppressor mechanism which is cell-intrinsically activated in the context of cellular stress. Senescence can further be propagated to neighbouring cells, a process called secondary senescence induction. Secondary senescence was initially shown as a paracrine response to the secretion of cytokines from primary senescent cells. More recently, juxtacrine Notch signalling has been implicated in mediating secondary senescence induction. Primary and secondary senescent induction results in distinct transcriptional outcomes. In addition, cell type and the stimulus in which senescence is induced can lead to variations in the phenotype of the senescence response. It is unclear whether heterogeneous senescent end-points are associated with distinct cellular function in situ, presenting functional heterogeneity. Thus, understanding senescence heterogeneity could prove to be important when devising ways of targeting senescent cells by senolytics, senostatics or senogenics. In this review, we discuss a role for functional heterogeneity in senescence in tissue- and cell-type specific manners, highlighting potential differences in senescence outcomes of primary and secondary senescence.

Keywords: Notch; heterogeneity; secondary senescence; senescence; senotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests associated with the manuscript.

Figures

Figure 1.
Figure 1.. Examples of cellular senescence heterogeneity.
(A) Senescence is a cell-type specific response. Fibroblasts and pancreatic beta-cells respond by up/down-regulating cell-type specific transcripts and proteins. (B) Senescence response varies by inducing oncogene. Although part of the same pathway, RAS and RAF-induced senescence show marked differences in fibroblasts. RAS-induced cells grow in size and form vacuoles. RAF-induced cells show a very high percentage of SAHF positive cells. (C) Cell-to-cell variability in oncogene-induced senescence. We have recently shown that RAS induction can lead to a variety of transcriptional end-points. We find an additional, secondary senescent end-point characterised by Notch signaling [30]. (D) A composite phenotype results in secondary senescence. Secondary senescence induction can be mediated by primary senescent cells through SASP and Notch.

Similar articles

  • Induction and transmission of oncogene-induced senescence.
    Rattanavirotkul N, Kirschner K, Chandra T. Rattanavirotkul N, et al. Cell Mol Life Sci. 2021 Feb;78(3):843-852. doi: 10.1007/s00018-020-03638-0. Epub 2020 Sep 16. Cell Mol Life Sci. 2021. PMID: 32936311 Free PMC article. Review.
  • Notch Signaling Mediates Secondary Senescence.
    Teo YV, Rattanavirotkul N, Olova N, Salzano A, Quintanilla A, Tarrats N, Kiourtis C, Müller M, Green AR, Adams PD, Acosta JC, Bird TG, Kirschner K, Neretti N, Chandra T. Teo YV, et al. Cell Rep. 2019 Apr 23;27(4):997-1007.e5. doi: 10.1016/j.celrep.2019.03.104. Cell Rep. 2019. PMID: 31018144 Free PMC article.
  • Notch and Senescence.
    Hoare M, Narita M. Hoare M, et al. Adv Exp Med Biol. 2018;1066:299-318. doi: 10.1007/978-3-319-89512-3_15. Adv Exp Med Biol. 2018. PMID: 30030833 Review.
  • Induction of Fibroblast Senescence During Mouse Corneal Wound Healing.
    Wang X, Qu M, Li J, Danielson P, Yang L, Zhou Q. Wang X, et al. Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3669-3679. doi: 10.1167/iovs.19-26983. Invest Ophthalmol Vis Sci. 2019. PMID: 31469894
  • Senescent cardiac fibroblasts: A key role in cardiac fibrosis.
    Osorio JM, Espinoza-Pérez C, Rimassa-Taré C, Machuca V, Bustos JO, Vallejos M, Vargas H, Díaz-Araya G. Osorio JM, et al. Biochim Biophys Acta Mol Basis Dis. 2023 Apr;1869(4):166642. doi: 10.1016/j.bbadis.2023.166642. Epub 2023 Jan 18. Biochim Biophys Acta Mol Basis Dis. 2023. PMID: 36669578 Review.

Cited by

References

    1. Hayflick L. and Moorhead P.S. (1961) The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585–621 10.1016/0014-4827(61)90192-6 - DOI - PubMed
    1. Serrano M., Lin A.W., McCurrach M.E., Beach D. and Lowe S.W. (1997) Oncogenic Ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602 10.1016/S0092-8674(00)81902-9 - DOI - PubMed
    1. Lin A.W., Barradas M., Stone J.C., Van Aelst L., Serrano M. and Lowe S.W. (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12, 3008–3019 10.1101/gad.12.19.3008 - DOI - PMC - PubMed
    1. Baker D.J., Perez-Terzic C., Jin F., Pitel K.S., Niederländer N.J., Jeganathan K. et al. (2008) Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nat. Cell Biol. 10, 825–836 10.1038/ncb1744 - DOI - PMC - PubMed
    1. Baker D.J., Wijshake T., Tchkonia T., LeBrasseur N.K., Childs B.G., van de Sluis B. et al. (2011) Clearance of p16 Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232–236 10.1038/nature10600 - DOI - PMC - PubMed

Publication types